Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Collagenase ointment for acute traumatic wounds
ChiCTR2300076576Phase 4Completed
- Sponsor
- Fourth Medical Center of PLA General Hospital
- Start
- Sep 2023
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of collagenase clostridium histolyticum in Abrasion, bruise, soft tissue laceration and 1 more (2 arms), sponsored by Fourth Medical Center of PLA General Hospital. Primary endpoint: Epithelial coverage rate of wound surface on day 7 of treatment. Started Sep 2023; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Abrasionbruisesoft tissue lacerationtraumatic wound
Beyond the preview
Go deeper on ChiCTR2300076576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076576.